HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hirotaka Onoe Selected Research

leucine methyl ester

11/2021Synthesis of L-[5-11 C]Leucine and L-α-[5-11 C]Methylleucine via Pd0 -mediated 11 C-Methylation and Microfluidic Hydrogenation: Potentiality of Leucine PET Probes for Tumor Imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hirotaka Onoe Research Topics

Disease

7Neoplasms (Cancer)
11/2021 - 04/2012
7Parkinson Disease (Parkinson's Disease)
01/2017 - 11/2011
6Neuroinflammatory Diseases
11/2022 - 04/2010
5Alzheimer Disease (Alzheimer's Disease)
01/2017 - 01/2012
4Neurodegenerative Diseases (Neurodegenerative Disease)
11/2022 - 07/2011
4Glaucoma
01/2013 - 01/2009
3Inflammation (Inflammations)
11/2022 - 04/2010
3Pain (Aches)
06/2013 - 11/2009
3Mental Disorders (Mental Disorder)
02/2013 - 01/2012
3Fatigue
02/2007 - 11/2002
2Ischemia
09/2015 - 10/2013
2Brain Ischemia (Cerebral Ischemia)
09/2012 - 11/2006
2Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
01/2012 - 12/2004
1Epilepsy (Aura)
12/2019
1Glut1 Deficiency Syndrome
12/2019
1Retinal Degeneration
01/2019
1Autistic Disorder (Autism)
01/2017
1Burns
01/2017
1Autism Spectrum Disorder
01/2017
1Tauopathies
01/2017
1Uremia
06/2016
1Amyloid Plaque
02/2016
1Cognitive Dysfunction
01/2016
1Atherosclerotic Plaque (Atheroma)
01/2016
1Glioma (Gliomas)
12/2015
1Adenocarcinoma
12/2015
1Brain Diseases (Brain Disorder)
08/2014
1Brain Injuries (Brain Injury)
10/2013
1Hyperalgesia
06/2013
1Treatment-Resistant Depressive Disorder
02/2013
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
02/2013
1Schizophrenia (Dementia Praecox)
02/2013
1Memory Disorders (Memory Loss)
02/2013
1Catalepsy
01/2013
1Reperfusion Injury
09/2012

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
01/2016 - 02/2007
4EstersIBA
11/2022 - 04/2010
4LipopolysaccharidesIBA
11/2022 - 04/2010
4ketoprofen methyl esterIBA
11/2022 - 07/2011
4Proteins (Proteins, Gene)FDA Link
12/2019 - 01/2012
4EnzymesIBA
02/2016 - 02/2007
3Cyclooxygenase 1IBA
11/2022 - 07/2011
3AcidsIBA
11/2022 - 04/2010
3ProstaglandinsIBA
02/2016 - 04/2010
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
02/2016 - 04/2010
3LigandsIBA
01/2012 - 11/2006
2Indicators and Reagents (Reagents)IBA
01/2021 - 01/2012
2Serotonin (5 Hydroxytryptamine)IBA
01/2017 - 12/2004
2Cholinergic Agents (Cholinergics)IBA
01/2017 - 01/2012
2Oxygen (Dioxygen)IBA
09/2015 - 11/2006
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
08/2014 - 04/2010
2Glutamic Acid (Glutamate)FDA Link
02/2013 - 01/2012
2MGS 0028IBA
02/2013 - 01/2012
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
10/2012 - 08/2012
2GABA-A Receptors (GABA(A) Receptor)IBA
01/2012 - 11/2009
2Neurotransmitter Agents (Neurotransmitter)IBA
12/2004 - 11/2002
1Ketoprofen (Orudis)FDA LinkGeneric
11/2022
1leucine methyl esterIBA
11/2021
1Leucine (L-Leucine)FDA Link
11/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021
1IntegrinsIBA
01/2021
1arginyl-glycyl-aspartic acidIBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
12/2019
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
12/2019
1AcetylcholinesteraseIBA
01/2017
1Advanced Glycation End ProductsIBA
06/2016
1AsparagineIBA
05/2016
1Polysaccharides (Glycans)IBA
05/2016
1AlbuminsIBA
05/2016
1Deoxyglucose (2 Deoxy D glucose)IBA
01/2016
12- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
01/2016
1ThymidineIBA
12/2015
1Stavudine (Zerit)FDA LinkGeneric
12/2015
11- methyl- 5- (3- azido- 2,3- dideoxy- beta- pentofuranosyl)uracilIBA
12/2015
1NucleosidesIBA
12/2015
1rofecoxib (Vioxx)FDA Link
10/2013
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2013
1Celecoxib (Celebrex)FDA Link
10/2013
1acromelic acid AIBA
06/2013
1Dihydrotachysterol (AT 10)IBA
06/2013
1UBP296IBA
06/2013
1PoisonsIBA
06/2013
1(2S,3R,4R)- 3- carboxymethyl- 4- (phenylthio)pyrrolidine- 2- carboxylic acidIBA
06/2013
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
06/2013
1Kainic Acid (Kainate)IBA
06/2013
1Peptides (Polypeptides)IBA
05/2013
1Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
02/2013
1CorticosteroneIBA
02/2013
1Lurasidone HydrochlorideFDA Link
01/2013
1Antipsychotic Agents (Antipsychotics)IBA
01/2013
1Arachidonic Acid (Vitamin F)IBA
09/2012
120-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
09/2012
1imidazoleIBA
09/2012

Therapy/Procedure

8Therapeutics
01/2021 - 07/2011
4Lasers (Laser)
01/2017 - 03/2011
3Light Coagulation
01/2017 - 03/2011
2Transplantation
01/2019 - 01/2013
1Intravenous Injections
11/2021
1Cell Transplantation
04/2016
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2013